Literature DB >> 29502728

Medical Management of Otosclerosis.

Norma de Oliveira Penido1, Andy de Oliveira Vicente2.   

Abstract

Otosclerosis/otospongiosis is a primary osteodystrophy of the otic capsule that affects genetically predisposed individuals and leads to progressive hearing loss. Diagnosis is usually clinical, based on the findings of anamnesis, physical examination, and audiometric evaluation. However, high-resolution computed tomography scan and MRI have played an important role in the diagnosis and therapeutic approach of otosclerosis and in assisting in the differential diagnosis. The therapeutic approach is aimed at preventing, or at least minimizing, disease progression while attempting to restore hearing. The use of sodium fluoride and bisphosphonates can be an important adjunct, perhaps even primary treatment, in managing active lesions.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed tomography; Hearing loss; MRI; Otosclerosis; Otospongiosis; Sodium alendronate; Sodium fluoride

Mesh:

Substances:

Year:  2018        PMID: 29502728     DOI: 10.1016/j.otc.2017.11.006

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  1 in total

Review 1.  Bisphosphonate therapy in otosclerosis: A scoping review.

Authors:  René E Zimmerer; Robert E Africa; Zack K Westenhaver; Brian J McKinnon
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-01-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.